Ovarian cancer of low malignant potential is not associated with positive familial history [7]

American Journal of Obstetrics and Gynecology

Volumn 175, Issue 2, 1996, Pages 507-508

  Shushan, A ^a   Paltiel, O ^a   Gordon, L ^a   Schenker, J G ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY TUMOR; OVULATION INDUCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0029842140     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(96)70181-3     Document Type: Letter

References (3)

1. JP Struewing D Abeliovich T Peretz N Avishai MM Kaback FJ Collins The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals Nature Genet 11 1995 198 200
2. S Narod P Tonin H Lynch P Watson J Feunteun G Lenoir Histology of BRCA1-associated ovarian tumors Lancet 343 1994 236
3. A Shushan O Paltiel J Iscovich U Elchalal T Peretz JG Schenker Human menopausal gonadotropin and the risk of epithelial ovarian cancer Fertil Steril 65 1996 8 13